American Pharmaceutical supplier problems delay ceftriaxone

American Pharmaceutical Partners announced it doesn't expect to get approval for its version of ceftriaxone for injection soon, citing information the drug company received this week from a raw material supplier that was inspected by the Food and Drug Administration. Ceftriaxone is the generic form of Roche's Rocephin, a cephalosporin antibiotic.

- read this report from TheStreet.com for more

Suggested Articles

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.

GSK poaches Merck KGaA's Martinez-Davis to helm pharma stateside; Bulto named Novartis U.S. pharma head; Allergan's Saunders set for huge parachute.